Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene - PubMed (original) (raw)
. 2002 Jun 15;62(12):3387-94.
Affiliations
- PMID: 12067980
Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene
Katrina M Comerford et al. Cancer Res. 2002.
Abstract
The microenvironment of rapidly growing tumors is associated with increased energy demand and diminished vascular supply, resulting in focal areas of prominent hypoxia. A number of hypoxia-responsive genes have been associated with growing tumors, and here we demonstrate that the multidrug resistance (MDR1) gene product P-glycoprotein, a Mr approximately 170,000 transmembrane protein associated with tumor resistance to chemotherapeutics, is induced by ambient hypoxia. Initial studies using quantitative microarray analysis of RNA revealed an approximately 7-fold increase in MDR in epithelial cells exposed to hypoxia (pO(2) 20 torr, 18 h). These findings were further confirmed at the mRNA and protein level. P-Glycoprotein function was studied by analysis of verapamil-inhibitable efflux of digoxin and rhodamine 123 in intact T84 cells and revealed that hypoxia enhances P-glycoprotein function by as much as 7 +/- 0.4-fold over normoxia. Subsequent studies confirmed hypoxia-elicited MDR1 gene induction and increased P-glycoprotein expression in nontransformed, primary cultures of human microvascular endothelial cells, and analysis of multicellular spheroids subjected to hypoxia revealed increased resistance to doxorubicin. Examination of the MDR1 gene identified a binding site for hypoxia inducible factor-1 (HIF-1), and inhibition of HIF-1 expression by antisense oligonucleotides resulted in significant inhibition of hypoxia-inducible MDR1 expression and a nearly complete loss of basal MDR1 expression. Studies using luciferase promoter constructs revealed a significant increase in activity in cells subjected to hypoxia, and such hypoxia inducibility was lost in truncated constructs lacking the HIF-1 site and in HIF-1 binding site mutants. Extensions of these studies also identified a role for Sp1 in this hypoxia response. Taken together, these data indicate that the MDR1 gene is hypoxia responsive, and such results may identify hypoxia-elicited P-glycoprotein expression as a pathway for resistance of some tumors to chemotherapeutics.
Similar articles
- c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia.
Comerford KM, Cummins EP, Taylor CT. Comerford KM, et al. Cancer Res. 2004 Dec 15;64(24):9057-61. doi: 10.1158/0008-5472.CAN-04-1919. Cancer Res. 2004. PMID: 15604272 - [Hypoxia-inducible factor-1 alpha dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell].
Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX, Wang HP. Zhu H, et al. Zhonghua Wai Ke Za Zhi. 2005 Mar 1;43(5):277-81. Zhonghua Wai Ke Za Zhi. 2005. PMID: 15842930 Chinese. - Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH, Melillo G. Rapisarda A, et al. Cancer Res. 2002 Aug 1;62(15):4316-24. Cancer Res. 2002. PMID: 12154035 - Hypoxia, clonal selection, and the role of HIF-1 in tumor progression.
Semenza GL. Semenza GL. Crit Rev Biochem Mol Biol. 2000;35(2):71-103. doi: 10.1080/10409230091169186. Crit Rev Biochem Mol Biol. 2000. PMID: 10821478 Review. - Hypoxia and hypoxia inducible factors (HIF) as important regulators of tumor physiology.
Acker T, Plate KH. Acker T, et al. Cancer Treat Res. 2004;117:219-48. doi: 10.1007/978-1-4419-8871-3_14. Cancer Treat Res. 2004. PMID: 15015563 Review.
Cited by
- Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
Zhu ZJ, Pang Y, Jin G, Zhang HY, Wang WH, Liu JW, Tuo GX, Wu P, Yang Y, Wang ZQ, Wang K. Zhu ZJ, et al. Aging (Albany NY). 2021 Jun 3;13(13):17155-17176. doi: 10.18632/aging.203062. Epub 2021 Jun 3. Aging (Albany NY). 2021. PMID: 34081626 Free PMC article. - Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.
Li S, Wei Q, Li Q, Zhang B, Xiao Q. Li S, et al. Cancer Biol Ther. 2015;16(6):866-75. doi: 10.1080/15384047.2015.1040958. Cancer Biol Ther. 2015. PMID: 25920936 Free PMC article. - Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier Level.
Al Rihani SB, Darakjian LI, Deodhar M, Dow P, Turgeon J, Michaud V. Al Rihani SB, et al. Int J Mol Sci. 2021 Apr 3;22(7):3742. doi: 10.3390/ijms22073742. Int J Mol Sci. 2021. PMID: 33916769 Free PMC article. Review. - Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1.
Chou CW, Wang CC, Wu CP, Lin YJ, Lee YC, Cheng YW, Hsieh CH. Chou CW, et al. Neuro Oncol. 2012 Oct;14(10):1227-38. doi: 10.1093/neuonc/nos195. Epub 2012 Sep 3. Neuro Oncol. 2012. PMID: 22946104 Free PMC article. - Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.
Luo Z, Tian H, Liu L, Chen Z, Liang R, Chen Z, Wu Z, Ma A, Zheng M, Cai L. Luo Z, et al. Theranostics. 2018 Jun 7;8(13):3584-3596. doi: 10.7150/thno.25409. eCollection 2018. Theranostics. 2018. PMID: 30026868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources